Anticholinergic effects of oral antipsychotic drugs of typicals versus atypicals over medium- and long-term: Systematic review and meta-analysis

Current Medicinal Chemistry

Volumn 19, Issue 30, 2012, Pages 5214-5218

  Ozbilen, M ^a   Adams, C E ^a   Marley, J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Anticholinergic effects; Antipsychotic drugs; Blurred vision; Constipation; Dry mouth; Schizophrenia; Trials

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOMOCRAN PHOSPHATE; CLOZAPINE; HALOPERIDOL; LOXAPINE; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; PENFLURIDOL; PERPHENAZINE; PIMOZIDE; PLACEBO; QUETIAPINE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE; UNCLASSIFIED DRUG;

ANTICHOLINERGIC EFFECT; BLURRED VISION; CONFUSION; CONSTIPATION; HUMAN; HYPERSALIVATION; HYPERTHERMIA; META ANALYSIS; NASAL STIFFNESS; NOSE DISEASE; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; TACHYCARDIA; TREATMENT DURATION; URINE RETENTION; XEROSTOMIA;

ANTIPSYCHOTIC AGENTS; CHOLINERGIC ANTAGONISTS; HUMANS; SCHIZOPHRENIA;

EID: 84870470964     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803530476     Document Type: Review

References (18)

1. Ozbilen, M.; Adams, C.E. Systematic overview of Cochrane reviews for anticholinergic effects of antipsychotic drugs. J Clin Psychopharmacol, 2009, 29, (2), 141-146.
2. Morrison, P.; Gaskill, D.; Meehan, T.; Lunney, P.; Lawrence, G.; Collings, P. The use of the Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) in clinical practice. Aust N Z J Ment Health Nurs, 2000, 9, (4), 166-176.
3. Banerjee, S.; Morgan, J.; Lewis, M.; Rowe, D.; White, M. A survey of clinical care for patients with schizophrenic disorders and learning disability. Journal of Clinical Excellence, 2001, 3, (3), 125-131.
4. Barbui, C.; Nose, M.; Bindman, J.; Schene, A.; Becker, T.; Mazzi, M.A.; Kikkert, M.; Camara, J.; Born, A.; Tansella, M. Sex differences in the subjective tolerability of antipsychotic drugs. J Clin Psychopharmacol, 2005, 25, (6), 521-526.
5. Feinberg, M. The problems of anticholinergic adverse effects in older patients. Drugs Aging, 1993, 3, (4), 335-348.
6. Beaumont, G. Antipsychotics-the future of schizophrenia treatment. Curr Med Res Opin, 2000, 16, (1), 37-42.
7. Meirik, K.; Linaker, O.M. Factors that influence self-reported compliance for neuroleptics. EUR J PSYCH, 2001, 15, (1), 5-12.
8. Misdrahi, D.; Llorca, P.M.; Lancon, C.; Bayle, F.J. Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications. Encephale, 2002, 28, (3 Pt 1), 266-272.
9. Rosenberg, K.P.; Bleiberg, K.L.; Koscis, J.; Gross, C. A survey of sexual side-effects among severely mentally ill patients taking psychotropic medications: impact on compliance. J Sex Marital Ther, 2003, 29, (4), 289-296.
10. Westheide, J.; Helmstaedter, C.; Elger, C.; Cooper-Mahkorn, D.; Strater, B.; Maier, W.; Kuhn, K.U. Sexuality in male psychiatric inpatients. a descriptive comparison of psychiatric patients, patients with epilepsy and healthy volunteers. Pharmacopsychiatry, 2007, 40, (5), 183-190.
11. Marshall, M.; Lockwood, A.; Bradley, C.; Adams, C.; Joy, C.; Fenton, M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. Br J Psychiatry, 2000, 176, 249-252.
12. Armitage, P. Should we cross off the crossover? Br J Clin Pharmacol, 1991, 32, (1), 1-2.
13. Wilson, E.B. Calculating a confidence interval of a proportion. Journal of the American Statistical Association, 1927, 22, 209-212.
14. Montgomery, J.H. Industry funding and author-industry affiliation in clinical trials in psychiatry. Am J Psychiatry, 2006, 163, (6), 1110-1111; author reply 1111.
15. Heres, S.; Davis, J.; Maino, K.; Jetzinger, E.; Kissling, W.; Leucht, S. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am J Psychiatry, 2006, 163, (2), 185-194.
16. De Hert, M.; Wampers, M.; Van Winkel, R.; Jozef Peuskens, J. Anticholinergic use in hospitalised schizophrenic patients in Belgium Psychiatry Research, 2007, 152, (2-3), 165-172.
17. Ozbilen, M. Systematic review and meta analysis of anticholinergic effects of antipsychotic drugs. MMedSc, Leeds University, Leeds, 2007.
18. The Electronic Medicines Compendium. 2012. Available at http://www.medicines.org.uk/emc/. Accessed 20.6.12.